Clinical trials
Posterior Cortical Atrophy (PCA) clinical trials
Below are recruiting posterior cortical atrophy (pca) clinical trials, each written for real people, not researchers. We’re tracking 6 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07191327Recruiting
Testing brain stimulation for posterior cortical atrophy
This study tests a noninvasive brain stimulation technique called HD-tDCS to see if it can help people with posterior cortical atrophy (PCA), a condition that affects vision and spatial skills. You would receive personalized stimulation sessions, and the study aims to learn if this treatment improves symptoms.
Ann Arbor, MichiganAges 50 years+ - NCT02740634Recruiting
Brain imaging study for Alzheimer's disease
This study uses brain scans to understand Alzheimer's disease and related conditions that affect memory, language, or vision. It looks at how changes in the brain happen over time in people with these diagnoses.
Rochester, MinnesotaAges 21–80 - NCT04715399Recruiting
Research study collecting data for neurodegenerative diseases
This study collects health information from people with neurodegenerative diseases, some family members, and healthy controls to help researchers better understand these conditions. It may help future diagnosis and research, and participation may include noninvasive checks and other procedures depending on your situation.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07222605Enrolling by invitation
MemorEM device study for brain diseases
This study tests a device called MemorEM to see how it works for people with brain diseases that cause memory and thinking problems (like Alzheimer's, Parkinson's, and ALS). It aims to understand your experience with the device.
Atlanta, GeorgiaAges 45–100 - NCT07049341Enrolling by invitation
A pilot trial of the MemorEM device for neurological diseases
This trial tests a device called MemorEM to see how patients with neurological diseases like Alzheimer's or Parkinson's experience it. It aims to understand if the device is comfortable and easy to use.
Tampa, FloridaAges 45–100 - NCT04150198Recruiting
PET-MR brain scan study of resilience in Alzheimer’s
This study uses a combined PET and MRI brain scan to understand why some people with Alzheimer’s (and related “focal” types) may cope better than expected. It may help researchers find brain patterns linked to resilience and to different Alzheimer’s subtypes.
OrsayAges 40–80
Hear when a new Posterior Cortical Atrophy (PCA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for posterior cortical atrophy (pca)?
- Yes. Clin2 currently lists 6 recruiting posterior cortical atrophy (pca) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a posterior cortical atrophy (pca) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a posterior cortical atrophy (pca) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.